WILLF (Demant AS) Debt-to-Asset : 0.48 (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Demant AS Debt-to-Asset?

Demant AS's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $153 Mil. Demant AS's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $2,049 Mil. Demant AS's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2024 was $4,556 Mil. Demant AS's debt to asset for the quarter that ended in Dec. 2024 was 0.48.

Demant AS Debt-to-Asset Historical Data

The historical data trend for Demant AS's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Demant AS Debt-to-Asset Chart

Demant AS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-Asset

Get a 7-Day Free Trial

0.41

0.46

0.51

0.47

0.48

Demant AS Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Debt-to-Asset	Get a 7-Day Free Trial															0.51	0.48	0.47	0.49	0.48

Competitive Comparison of Demant AS's Debt-to-Asset

For the Medical Devices subindustry, Demant AS's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Demant AS's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Demant AS's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Demant AS's Debt-to-Asset falls into.

Save Embed

;

Save Embed

;

Demant AS Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Demant AS's Debt-to-Asset for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(153.045	+	2048.694)	/	4556.24
	=	0.48

Demant AS's Debt-to-Asset for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(153.045	+	2048.694)	/	4556.24
	=	0.48

Demant AS (OTCPK:WILLF) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Demant AS Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Demant AS's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Demant AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Demant AS (OTCPK:WILLF) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

WILYY:USA DEMANc:UK 0RGT:UK DEMANT:Denmark WDH1:Germany DEMA:Austria

Address

Kongebakken 9, Smorum, DNK, 2765

Website

https://www.demant.com

Demant AS is a Denmark-based company engaged in the healthcare industry. The company develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Group focuses on four business areas: Hearing Devices, including such brands as Bernafon, Oticon, Frontrow, Phonic Ear and Sonic; Hearing Implants, including Oticon Medical; Diagnostic Instruments. The Company operates through more than 90 subsidiaries and associates all around the world. More than 80% of the company's sales come from North America and Europe.